Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
79 | 3 | CARDIAC & CARDIOVASCULAR SYSTEM//CARDIOL//PERCUTANEOUS CORONARY INTERVENTION | 84810 |
107 | 2 | CLOPIDOGREL//ACUTE CORONARY SYNDROME//CARDIAC & CARDIOVASCULAR SYSTEM | 25534 |
26663 | 1 | DUAL ANTIPLATELET THERAPY//HOSP UNIV FIBROSE INFLAMMAT REMODELAGE//DUAL ANTIPLATELET THERAPY DAPT | 269 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | DUAL ANTIPLATELET THERAPY | authKW | 1874980 | 23% | 25% | 63 |
2 | HOSP UNIV FIBROSE INFLAMMAT REMODELAGE | address | 468650 | 1% | 100% | 4 |
3 | DUAL ANTIPLATELET THERAPY DAPT | authKW | 468646 | 2% | 67% | 6 |
4 | SMITH OUTCOMES CARDIOL | address | 273370 | 3% | 33% | 7 |
5 | P2Y12 INHIBITOR | authKW | 248101 | 2% | 35% | 6 |
6 | DIPARTIMENTO CARDIOTORACOVASC | address | 244073 | 4% | 21% | 10 |
7 | INSERM U1148 HOSP UNIV FIBROSIS INFLAMMAT | address | 234325 | 1% | 100% | 2 |
8 | INTERVENT CARDIOVASC CLIN TRIALS | address | 225307 | 2% | 38% | 5 |
9 | DUAL ANTI PLATELET THERAPY | authKW | 170413 | 1% | 36% | 4 |
10 | DRUG ELUTING STENT | authKW | 156868 | 22% | 2% | 59 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 11183 | 79% | 0% | 212 |
2 | Medicine, General & Internal | 208 | 14% | 0% | 38 |
3 | Peripheral Vascular Diseases | 160 | 8% | 0% | 21 |
4 | Pharmacology & Pharmacy | 8 | 6% | 0% | 16 |
5 | Health Care Sciences & Services | 6 | 1% | 0% | 4 |
6 | Health Policy & Services | 2 | 1% | 0% | 2 |
7 | Primary Health Care | 2 | 0% | 0% | 1 |
8 | Respiratory System | 0 | 1% | 0% | 2 |
9 | Anesthesiology | 0 | 0% | 0% | 1 |
10 | Urology & Nephrology | -1 | 0% | 0% | 1 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HOSP UNIV FIBROSE INFLAMMAT REMODELAGE | 468650 | 1% | 100% | 4 |
2 | SMITH OUTCOMES CARDIOL | 273370 | 3% | 33% | 7 |
3 | DIPARTIMENTO CARDIOTORACOVASC | 244073 | 4% | 21% | 10 |
4 | INSERM U1148 HOSP UNIV FIBROSIS INFLAMMAT | 234325 | 1% | 100% | 2 |
5 | INTERVENT CARDIOVASC CLIN TRIALS | 225307 | 2% | 38% | 5 |
6 | INSERMU114 | 156215 | 1% | 67% | 2 |
7 | PARTNER STATE PHARMACEUT BIOTECHNOL | 156215 | 1% | 67% | 2 |
8 | ACT STUDY GRP | 133894 | 1% | 29% | 4 |
9 | ACTION GRP HP | 117163 | 0% | 100% | 1 |
10 | ACTION STUDY GRPHEART | 117163 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JAMA CARDIOLOGY | 14934 | 2% | 3% | 5 |
2 | CIRCULATION-CARDIOVASCULAR INTERVENTIONS | 12149 | 3% | 1% | 9 |
3 | JACC-CARDIOVASCULAR INTERVENTIONS | 8789 | 4% | 1% | 10 |
4 | EUROINTERVENTION | 6205 | 3% | 1% | 9 |
5 | EUROPEAN HEART JOURNAL | 5013 | 8% | 0% | 21 |
6 | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 3894 | 9% | 0% | 23 |
7 | CARDIOVASCULAR THERAPEUTICS | 2164 | 1% | 1% | 3 |
8 | CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS | 2103 | 4% | 0% | 10 |
9 | REVISTA ESPANOLA DE CARDIOLOGIA | 1748 | 2% | 0% | 6 |
10 | CURRENT CARDIOLOGY REPORTS | 1589 | 1% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |